BioCryst Pharmaceuticals
Price & Volume
Stats
See moreOpen | $8.35 |
Previous Close | $8.28 |
Day Range | $8.19-$8.52 |
52W Range | $4.03-$9.50 |
Market Cap | $1.7B |
Shares Short | 17M |
Financials
See moreRevenue (12 Mos) | $450.7M |
Revenue Growth (YoY) | 40.8% |
Gross Profit (12 Mos) | $264.8M |
Diluted EPS | -$0.43 |
News
See moreYahoo Finance • 2 days ago
BioCryst Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations
Yahoo Finance • 2 days ago
BioCryst Reports Fourth Quarter and Full Year 2024 Financial Results and Upcoming Key Milestones
Yahoo Finance • 22 days ago
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 8 months ago
BioCryst Pharmaceuticals Insiders Added US$1.05m Of Stock To Their Holdings
About
CEO | Mr. Jon P. Stonehouse |
CFO | Mr. Anthony J. Doyle |
Address | 4505 Emperor Boulevard, Durham, NC, United States, 27703 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 536 |
